NALIRIFOX in first-line therapy for metastatic pancreatic adenocarcinoma

被引：0
作者：
Anglaret, Siriane [1 ]
Hilmi, Marc [2 ]
机构：
[1] Gustave Roussy, Dept Med Oncol, Villejuif, France
[2] Inst Curie, Dept Oncol Med, St Cloud, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 11期
关键词：
Pancreatic ductal adenocarcinoma; Metastatic; NALIRIFOX; IRINOTECAN; CANCER;
D O I：
10.1016/j.bulcan.2024.06.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：999 / 1000
页数：2
相关论文
共 10 条
  • [1] FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
    Conroy, Thierry
    Desseigne, Francoise
    Ychou, Marc
    Bouche, Olivier
    Guimbaud, Rosine
    Becouarn, Yves
    Adenis, Antoine
    Raoul, Jean-Luc
    Gourgou-Bourgade, Sophie
    de la Fouchardiere, Christelle
    Bennouna, Jaafar
    Bachet, Jean-Baptiste
    Khemissa-Akouz, Faiza
    Pere-Verge, Denis
    Delbaldo, Catherine
    Assenat, Eric
    Chauffert, Bruno
    Michel, Pierre
    Montoto-Grillot, Christine
    Ducreux, Michel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) : 1817 - 1825
  • [2] Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
    Dahan, Laetitia
    Williet, Nicolas
    Le Malicot, Karine
    Phelip, Jean-Marc
    Desrame, Jerome
    Bouche, Olivier
    Petorin, Caroline
    Malka, David
    Rebischung, Christine
    Aparicio, Thomas
    Lecaille, Cedric
    Rinaldi, Yves
    Turpin, Anthony
    Bignon, Anne-Laure
    Bachet, Jean-Baptiste
    Seitz, Jean-Francois
    Lepage, Come
    Francois, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (29) : 3242 - +
  • [3] Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy
    Drummond, DC
    Noble, CO
    Guo, ZX
    Hong, K
    Park, JW
    Kirpotin, DB
    [J]. CANCER RESEARCH, 2006, 66 (06) : 3271 - 3277
  • [4] nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
    Goldstein, David
    El-Maraghi, Robert Hassan
    Hammel, Pascal
    Heinemann, Volker
    Kunzmann, Volker
    Sastre, Javier
    Scheithauer, Werner
    Siena, Salvatore
    Tabernero, Josep
    Teixeira, Luis
    Tortora, Giampaolo
    Van Laethem, Jean-Luc
    Young, Rosemary
    Penenberg, Darryl Neil
    Lu, Brian
    Romano, Alfredo
    Von Hoff, Daniel D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (02):
  • [5] New drug approval: Olaparib - pancreatic cancer with BRCA germline mutation
    Hilmi, Marc
    Neuzillet, Cindy
    [J]. BULLETIN DU CANCER, 2020, 107 (10) : 961 - 962
  • [6] Lapotre-Ledoux Benedicte, 2023, Bulletin Epidemiologique Hebdomadaire, P188
  • [7] NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
    Nichetti, Federico
    Rota, Simone
    Ambrosini, Paolo
    Pircher, Chiara
    Gusmaroli, Eleonora
    Busset, Michele Droz Dit
    Pusceddu, Sara
    Sposito, Carlo
    Coppa, Jorgelina
    Morano, Federica
    Pietrantonio, Filippo
    Di Bartolomeo, Maria
    Mariani, Luigi
    Mazzaferro, Vincenzo
    de Braud, Filippo
    Niger, Monica
    [J]. JAMA NETWORK OPEN, 2024, 7 (01)
  • [8] Nab-paclitaxel plus gemcitabine versus modified FOLFIRINOX or S-IROX in metastatic or recurrent pancreatic cancer (JCOG1611, GENERATE): A multicentred, randomized, open-label, three-arm, phase II/III trial
    Ohba, A.
    Ozaka, M.
    Ogawa, G.
    Okusaka, T.
    Kobayashi, S.
    Yamashita, T.
    Ikeda, M.
    Yasuda, I.
    Sugimori, K.
    Sasahira, N.
    Ikezawa, K.
    Miki, I.
    Okano, N.
    Mizuno, N.
    Furukawa, M.
    Shirakawa, H.
    Sano, Y.
    Katayama, H.
    Furuse, J.
    Ueno, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S894 - S894
  • [9] NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3trial
    Wainberg, Zev A.
    Melisi, Davide
    Macarulla, Teresa
    Cid, Roberto Pazo
    Chandana, Sreenivasa R.
    De La Fouchardiere, Christelle
    Dean, Andrew
    Kiss, Igor
    Lee, Woo Jin
    Goetze, Thorsten O.
    Van Cutsem, Eric
    Paulson, A. Scott
    Bekaii-Saab, Tanios
    Pant, Shubham
    Hubner, Richard A.
    Xiao, Zhimin
    Chen, Huanyu
    Benzaghou, Fawzi
    O'Reilly, Eileen M.
    [J]. LANCET, 2023, 402 (10409) : 1272 - 1281
  • [10] First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study
    Wainberg, Zev A.
    Bekaii-Saab, Tanios
    Boland, Patrick M.
    Dayyani, Farshid
    Macarulla, Teresa
    Mody, Kabir
    Belanger, Bruce
    Maxwell, Fiona
    Moore, Yan
    Thiagalingam, Arunthathi
    Wang, Tiffany
    Zhang, Bin
    Dean, Andrew
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 151 : 14 - 24
1